LeMaitre Vascular, Inc.LMAT

$93.95+1.74 (+1.89%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$2B
Mid-cap
+660%
2016 — today
10-Year Price
+522%
2016 — today
52-Week Range
$79.77$117.39
Current $93.95· 38%

Operating worldwide, LeMaitre Vascular, Inc. specializes in the development, distribution, and maintenance of medical devices and implants for treating peripheral vascular disease. Its product portfolio encompasses a range of catheters, including angioscopes, which are fiberoptic tools for internal blood vessel visualization; embolectomy catheters for removing blood clots from arteries or veins; occlusion catheters that temporarily halt blood flow; perfusion catheters for infusing blood and other fluids into the vasculature; and thrombectomy catheters, featuring a silicone balloon for extracting venous thrombi. The company also furnishes carotid shunts, designed to temporarily redirect blood flow to the brain during carotid endarterectomy surgery to clear arterial plaque. Another offering is radiopaque tape, a medical-grade adhesive applied externally to help interventionists precisely cross-reference skin locations with underlying anatomical features like vessels or lesions. Further products include valvulotomes, instruments used to cut or disrupt valves within the saphenous vein, enabling it to function as an arterial bypass to carry blood past diseased arteries to the lower leg or foot. Additionally, LeMaitre supplies vascular grafts for bypassing or replacing compromised arteries. Moreover, the company provides vascular and cardiac patches for post-surgical vessel closure. Its closure systems employ titanium clips for connecting vessels, offering an alternative to traditional sutures. Products are distributed via both its direct sales force and a network of distributors. Founded in 1983 as Vascutech, Inc., the company rebranded as LeMaitre Vascular, Inc. in April 2001. It is headquartered in Burlington, Massachusetts.

Valuation in context

P/E ratio
34.7
Historically cheap
Historically cheap relative to the last 10 years
P/B ratio
5.3
Above average
Pricier than usual over the last 10 years
EV / EBITDA
24.2
Below average
Below the 10-year average
Dividend Yield
1.0%
Above average
Above the 10-year average
PEG ratio
1.9
Below average
Below the 10-year average
FCF Yield
3.7%
Near historic high
Near historic highs — last 10 years
Free · No credit card needed

Get alerted when LMAT is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.